Lung transplant recipients represent a vulnerable population at the intersection of autoimmunity and the COVID-19 pandemic. This review explores the complex interplay between post-transplant autoimmunity and COVID-19 in lung transplant recipients. We analyse the unique challenges faced by these patients, including increased susceptibility to infections, potential exacerbation of autoimmune reactions and the impact of immunosuppressive therapies. Key considerations include risk assessment, vaccination strategies and the evolving landscape of management protocols. By navigating this crossroads with a multidisciplinary approach that integrates immunology, transplantation and infectious disease expertise, healthcare providers can optimize patient care and outcomes.
HTML PDFShare this article
Transplantation Technologies & Research received 223 citations as per Google Scholar report
